Johnson & Johnson MedTech (NYSE: JNJ) announced that it has a new chief medical & scientific officer for its Electrophysiology unit.
Michael Bodner, group chair for Electrophysiology & Neurovascular, posted on LinkedIn that the company appointed Dr. Gregory Michaud to the role.
Michaud, a globally recognized electrophysiologist, brings significant experience in the diagnosis and treatment of AFib and complex arrhythmias. He serves as chief of the Arrhythmia Service at the Beth Israel Deaconess Medical Center. According to the AF Symposium website, he has played a pivotal role in developing better ablation strategies for AFib.
Bodner wrote that his role at Johnson & Johnson MedTech helps to expand clinical research and enhance procedural workflows while advancing the development of next-generation technologies. Michaud joins the company as it advances its its Omnypulse and Varipulse ablation systems, among other offerings.
“We’re entering an exciting next chapter for our Electrophysiology business—one that reflects our commitment to shaping the future of arrhythmia care through partnership and world-class talent,” Bodner wrote. “I’m pleased to announce that Dr. Gregory Michaud will be joining Johnson & Johnson MedTech as our new chief medical & scientific officer for Electrophysiology.
“Dr. Michaud’s experience and insight will help us better serve patients and customers, while pushing the boundaries of what’s possible.”
A Johnson & Johnson MedTech spokesperson shared the following statement from Michaud on his hiring with MassDevice via email:
“As a recognized leader in cardiac mapping and ablation, I believe J&J MedTech is uniquely positioned to shape the future of electrophysiology, and I look forward to advancing our research and innovations to further improve patient and procedural outcomes,” said Dr. Gregory Michaud. “Through a strong pipeline of innovative technologies backed by clinical research, world-class training programs and collaborative partnerships – we’re committed to supporting and educating the next generation of global electrophysiologists.”
